{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Sven Eyckerman"}, {"accession": "MS:1000589", "name": "contact email", "value": "sven.eyckerman@vib-ugent.be"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Medical Protein Research"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Kris Gevaert"}, {"accession": "MS:1000589", "name": "contact email", "value": "kris.gevaert@vib-ugent.be"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Medical Biotechnology Center, VIB, Ghent, Belgium. Department of Biochemistry, Ghent University, Ghent, Belgium;"}]}], "datasetFiles": [{"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002565/ms_lims_projects_none_to_PRIDE_20150720_150954.xml.gz"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002565/E05718_1t_4085_Noor_eleonora_gel2_090714 control2.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002565/E05720_1t_4085_Noor_eleonora_gel3_090714 control3.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002565/E05722_1t_4085_Noor_eleonora_gel4_090714 PD1.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002565/E05724_1t_4085_Noor_eleonora_gel5_090714 PD2.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002565/E05726_1t_4085_Noor_eleonora_gel6_090714 PD3.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002565/E06850_2p_4247_eleonora_band1 control1.raw"}], "description": "Focal amplifications of 3p13-3p14 occur in about 10% of melanoma and are associated with poor prognosis. The melanoma-specific oncogene MITF resides at the epicenter of this amplicon1 . However, whether other loci present in this amplicon also contribute to melanomagenesis is unknown. Here we show that the recently annotated long non-coding RNA gene LINC01212 is consistently cogained with MITF. In addition to being amplified, LINC01212 is a target of the lineage-specific transcription factor SOX10 and, consequently, it is expressed in more than 90% of human melanomas, but not in normal adult tissues. Whereas exogenous LINC01212 functions in trans to increase melanoma clonogenic potential, LINC01212 knock-down drastically decreases the viability of melanoma cells irrespective of their transcriptional cell state, BRAF, NRAS or TP53 status and increases their sensitivity to MAPK-targeting therapeutics both in vitro and in Patient-Derived Xenograft (PDX) models. Mechanistically, LINC01212 interacts with p32, a master regulator of mitochondrial homeostasis and metabolism, to increase its mitochondrial targeting and pro-oncogenic function. Our results indicate that targeting the lineage addiction oncogene LINC01212, especially in combination with BRAFV600Einhibitors, disrupts vital mitochondrial functions in a cancer-cell specific manner and is therefore expected to deliver highly effective and tissuerestricted anti-melanoma therapeutic responses.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002565"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD002565"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD002565"}, {"accession": "MS:1001922", "name": "Digital Object Identifier (DOI)", "value": "10.6019/PXD002565"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "lncRNA protein binding melanoma"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "MOD:00719", "name": "L-methionine sulfoxide", "value": "15.994915"}, {"accession": "MOD:00040", "name": "2-pyrrolidone-5-carboxylic acid (Gln)", "value": "-17.026549"}, {"accession": "MOD:01047", "name": "monohydroxylated lysine", "value": "15.994915"}, {"accession": "MOD:00408", "name": "N-acetylated residue", "value": "42.010565"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "27008969"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Leucci E, Vendramin R, Spinazzi M, Laurette P, Fiers M, Wouters J, Radaelli E, Eyckerman S, Leonelli C, Vanderheyden K, Rogiers A, Hermans E, Baatsen P, Aerts S, Amant F, Van Aelst S, van den Oord J, de Strooper B, Davidson I, Lafontaine DL, Gevaert K, Vandesompele J, Mestdagh P, Marine JC. Melanoma addiction to the long non-coding RNA SAMMSON. Nature. 2016 Mar 24;531(7595):518-22"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Targeting the lineage-specific long non-coding RNA LINC01212 as an effective anti-melanoma therapeutic strategy"}